These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28247188)

  • 21. Deferoxamine Treatment Prevents Post-Stroke Vasoregression and Neurovascular Unit Remodeling Leading to Improved Functional Outcomes in Type 2 Male Diabetic Rats: Role of Endothelial Ferroptosis.
    Abdul Y; Li W; Ward R; Abdelsaid M; Hafez S; Dong G; Jamil S; Wolf V; Johnson MH; Fagan SC; Ergul A
    Transl Stroke Res; 2021 Aug; 12(4):615-630. PubMed ID: 32875455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
    Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
    J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.
    Tan Z; Li X; Turner RC; Logsdon AF; Lucke-Wold B; DiPasquale K; Jeong SS; Chen R; Huber JD; Rosen CL
    Eur J Pharmacol; 2014 Sep; 738():368-73. PubMed ID: 24933645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
    Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
    Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
    Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex.
    Ward R; Valenzuela JP; Li W; Dong G; Fagan SC; Ergul A
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1402-H1413. PubMed ID: 30118341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats.
    Kawamura K; Takahashi T; Kanazawa M; Igarashi H; Nakada T; Nishizawa M; Shimohata T
    PLoS One; 2014; 9(6):e98639. PubMed ID: 24896569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats.
    Fan X; Ning M; Lo EH; Wang X
    Stroke; 2013 Jan; 44(1):255-9. PubMed ID: 23117722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
    Ishrat T; Pillai B; Ergul A; Hafez S; Fagan SC
    Neurochem Res; 2013 Dec; 38(12):2668-77. PubMed ID: 24194350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke.
    Zheng Y; Lieschke F; Schaefer JH; Wang X; Foerch C; van Leyen K
    Stroke; 2019 Dec; 50(12):3650-3653. PubMed ID: 31587659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
    Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
    Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.
    Wang Y; Zhao Z; Chow N; Rajput PS; Griffin JH; Lyden PD; Zlokovic BV
    Stroke; 2013 Dec; 44(12):3529-36. PubMed ID: 24159062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Decompressive Craniectomy on Hemorrhagic Transformation in Malignant Ischemic Stroke in Mice.
    Borha A; Lebrun F; Touzé E; Emery E; Vivien D; Gaberel T
    Stroke; 2023 Jan; 54(1):e1-e6. PubMed ID: 36475467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tissue plasminogen activator and annexin A2 combination therapy on long-term neurological outcomes of rat focal embolic stroke.
    Wang X; Fan X; Yu Z; Liao Z; Zhao J; Mandeville E; Guo S; Lo EH; Wang X
    Stroke; 2014 Feb; 45(2):619-22. PubMed ID: 24368559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
    Zhang L; Chopp M; Jia L; Cui Y; Lu M; Zhang ZG
    J Cereb Blood Flow Metab; 2009 Nov; 29(11):1816-24. PubMed ID: 19638998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.